Literature DB >> 3084541

Calcium-regulating hormones across the menstrual cycle.

K N Muse, S C Manolagas, L J Deftos, N Alexander, S S Yen.   

Abstract

Midcycle elevations of serum PTH, calcitonin (CT), and 1,25-dihydroxyvitamin D [1,25-(OH)2D] in women have been reported. To examine the effects of cyclic changes in ovarian steroid secretion on calcitropic hormone concentrations, we used a cytoreceptor assay for 1,25-(OH)2D and homologous RIAs for PTH and CT to measure these hormones in daily blood samples obtained from six women throughout the menstrual cycle. Significant changes in serum PTH, CT, 1,25-(OH)2D, calcium, and phosphorus concentrations during the cycle were not found; transverse means (+/- SE) were 101 +/- 3.5 pg/ml for PTH, 30.8 +/- 1.8 pg/ml for CT, and 40.1 +/- 1.7 pg/ml for 1,25-(OH)2D. In addition, CT reserve was assessed by calcium infusion (3 mg/kg, iv, in 10 min) during the early and late follicular and midluteal phases of the cycle. Although serum CT increased significantly (P less than 0.01) after calcium infusion, the mean (+/- SE) increment (23.2 +/- 2.2 pg/ml) did not significantly differ in the three phases of the cycle (early follicular, 23.8 +/- 4.0; late follicular, 23.3 +/- 3.4; midluteal, 22.5 +/- 4.1). Our data do not support previous reports of midcycle elevations in serum PTH, CT, and 1,25-(OH)2D concentrations, and we conclude that serum concentrations of the calcitropic hormones do not significantly vary during the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084541     DOI: 10.1210/jcem-62-6-1313

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Islet amyloid polypeptide (amylin) increases the renal excretion of calcium in the conscious dog.

Authors:  P D Miles; L J Deftos; A R Moossa; J M Olefsky
Journal:  Calcif Tissue Int       Date:  1994-10       Impact factor: 4.333

2.  Urinary biochemical markers for bone resorption during the menstrual cycle.

Authors:  I Gorai; O Chaki; M Nakayama; H Minaguchi
Journal:  Calcif Tissue Int       Date:  1995-08       Impact factor: 4.333

3.  Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.

Authors:  R Civitelli; D Agnusdei; P Nardi; F Zacchei; L V Avioli; C Gennari
Journal:  Calcif Tissue Int       Date:  1988-02       Impact factor: 4.333

4.  Calcium supplementation in premenstrual syndrome: a randomized crossover trial.

Authors:  S Thys-Jacobs; S Ceccarelli; A Bierman; H Weisman; M A Cohen; J Alvir
Journal:  J Gen Intern Med       Date:  1989 May-Jun       Impact factor: 5.128

5.  Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women.

Authors:  Yessica Agudelo-Zapata; Luis Miguel Maldonado-Acosta; Héctor Fabio Sandoval-Alzate; Natalia Elvira Poveda; María Fernanda Garcés; Jonathan Alexander Cortés-Vásquez; Andrés Felipe Linares-Vaca; Carlos Alejandro Mancera-Rodríguez; Shahar Alexandra Perea-Ariza; Karen Yuliana Ramírez-Iriarte; Camilo Andrés Castro-Saldarriaga; Juan Manuel Arteaga-Diaz; Roberto Franco-Vega; Edith Ángel-Müller; Arturo José Parada-Baños; Jorge E Caminos
Journal:  Endocr Connect       Date:  2018-04-17       Impact factor: 3.335

6.  Vitamin D metabolites across the menstrual cycle: a systematic review.

Authors:  Anita Subramanian; Alison D Gernand
Journal:  BMC Womens Health       Date:  2019-01-28       Impact factor: 2.809

7.  Vitamin D and Reproductive Hormones Across the Menstrual Cycle.

Authors:  Q E Harmon; K Kissell; A M Z Jukic; K Kim; L Sjaarda; N J Perkins; D M Umbach; E F Schisterman; D D Baird; S L Mumford
Journal:  Hum Reprod       Date:  2020-02-29       Impact factor: 6.918

Review 8.  Gender Predilection in Sporadic Parathyroid Adenomas.

Authors:  Maria P Yavropoulou; Athanasios D Anastasilakis; Argyro Panagiotakou; Evanthia Kassi; Polyzois Makras
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.